EZH2 and neoplasm: Indeed, several reports have shown that genetic silencing and pharmacologic inhibition of EZH2 induced cell apoptosis, inhibited cell invasion and tumor angiogenesis, ultimately suppressed cancer growth and progression [15, 16].